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cular shunts (IHVSs).
Patients and Methods: We systematically screened 3143 patients liable to develop IHVSs. Diag-
nosed patients were comprehensively evaluated using color Doppler and multiphasic CT. Our man-
agement strategy based on imaging and clinical ﬁndings and categorized patients into three groups
with different lines of management and we assessed the degree of shunt occlusion and clinical
outcome.
Results: IHVSs were diagnosed in 134 patients. Two types of shunts were identiﬁed; arteriovenous
(72%) and venovenous (28%). Small simple shunts (32%) showed no morphological or hemody-
namic changes. Small complex shunts (57%) showed mild alterations in Doppler spectra. Large
and aneurismal shunts (11%) showed increased diameters and ﬂow velocities of the shunt vessels
with alteration of ﬂow pattern. By CT the vessels opaciﬁed during the early arterial phases inElmoderia St. Teeba Tower,
22863.
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20 B.A.M. Dessouky et al.arteriovenous, and during the portovenous phase in venovenous shunts. During management,
group I included 42%; 38% were conservatively managed and 4% underwent TIPS. Group II
included 57% who underwent successful embolization in 50%, and <80% reduction in 7% of
patients who underwent surgery. Direct surgery was selected for 1% of patients.
Conclusion: Using color Doppler ultrasonography complemented by multiphasic CT allowed early
diagnosis and evaluation of IHVSs and selection of the suitable treatment. Our management strat-
egy allowed practical therapeutic implications and yielded good results.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Intrahepatic vascular shunts (IHVSs) are abnormal communi-
cations between intrahepatic vasculature involving the arterial,
portal or hepatic venous systems [1,2]. The etiology of these
shunts is controversial and may be either acquired, as those
associated with cirrhosis and/or hepatocellular carcinoma,
those that occur after traumatic injuries to the liver or inter-
ventional transhepatic procedures (including liver biopsy, tran-
shepatic cholangiography, or biliary surgery), or they may
appear in the form of congenital and idiopathic vascular mal-
formations, as in Rendu-Osler-Weber syndrome (hereditary
hemorrhagic telangiectasia) [3–5].
The recognition of intrahepatic vascular shunts by clinical
criteria alone has long been considered uncommon. They are
probably underestimated regarding their clinical relevance
and frequency of appearance. Congestive cardiac failure, por-
tal hypertension, portosystemic encephalopathy, cholangitis,
and atypical cirrhosis have been reported as possible serious
complications related to this condition. Thus, a correct diagno-
sis is important, and diagnostic imaging has a fundamental
role in identiﬁcation and evaluation of shunts and determina-
tion of appropriate management [4,6,7].
Ultrasonography, especially in association with color
Doppler has proved useful in the detection of intrahepatic vas-
cular shunts and has the additional advantage over other imag-
ing modalities that it enables recognition of ﬂow direction,
ﬂow velocity, and type of blood ﬂow (i.e., arterial, portal, or
hepatic venous) noninvasively [2,3,6]. Those are important
diagnostic aspects for the different types of vascular malforma-
tions. The introduction of multidetector CT, particularly in
association with a multiphasic study protocol, and angio-
graphic reconstructions makes their identiﬁcation easier than
in previous decades [4,8].
The purpose of the present study is to propose a strategy
for early diagnosis, and management of intrahepatic vascular
shunts based on our experience and a review of the literature.
2. Patients and methods
This prospective study was conducted between April 2008 and
October 2010 on 3153 consecutive patients who were liable to
develop intrahepatic vascular shunts (IHVSs). Ten patients; six
had renal insufﬁciency and four had history of severe adverse
reactions to iodinated contrast agents were primarily excluded
from the study, so the total number of patients included was
3143 patients. We proposed our systematic screening program
as a part of follow up of patients who had diagnosed liver cir-
rhosis (n= 2318) and HCC (n= 752) based on US and tri-
phasic CT ﬁndings, 916 of them had previously underwentone or more interventional procedures including radiofre-
quency ablation, liver biopsy and/or and percutaneous ethanol
injection. Our study also included patients who had traumatic
liver injury (n= 29), patients who underwent transhepatic bil-
iary drainage (n= 21), patients with positive family history of
hereditary hemorrhagic telangiectasia (HHT) (n= 15) and pa-
tients with Budd-Chiari syndrome (n= 8). All the patients
were subjected to detailed history taking and full clinical exam-
ination prior to imaging evaluation. Our evaluation of intrahe-
patic vascular shunts involved two levels of diagnostic
examinations. The ﬁrst was gray scale ultrasound completed
by color and power-Doppler imaging and the second was mul-
tiphasic CT study. Targeted digital subtraction angiography
(DSA) was performed as recommended by our team in the
next step of the diagnostic ladder whenever intervention was
indicated. The gold standard of this study was based on the
information obtained from combined imaging ﬁndings and/
or surgery.
2.1. Imaging studies
2.1.1. Ultrasonography
We used sonographic machines with real time B-mode imag-
ing, coupled with pulsed, color and power Doppler, with 3.5
and 5 MHz convex transducers (Siemens sienna Erlangen,
Germany, Nemio XG and Xario, Toshiba, Tokyo, Japan).
The sonographic studies began with a preliminary morpho-
logic evaluation of the liver and abdomen with special empha-
sis on the intrahepatic vasculature to screen for the presence
and identity of a vascular shunt, and to evaluate the hemody-
namic effects of the shunt on intrahepatic circulation.
2.1.2. Computed tomography
Computed tomography of the abdomen was performed for pa-
tients in whom intrahepatic vascular shunts were identiﬁed by
ultrasound to conﬁrm ultrasound ﬁndings and assess intrahe-
patic parenchymal perfusion changes. We used 16-detector
CT scanners (Toshiba Aquillion, Tokyo, Japan and Siemens
Somatom, deﬁnition AS, Germany). Gastrointestinal contrast
medium was not administered. CT scanning started with an
unenhanced CT acquisition then intravenous bolus injection
of nonionic contrast material (Omnipaque, iohexol 350 mg/
mL, Amersham Health) was administered at a dose of 1.5–
2 mL/kg body weight with a maximal amount of 150 mL
and a ﬂow rate of 4 mL/s through a 22-gauge IV catheter in-
serted into an antecubital vein using an automatic injector
(MEDRAD). Four sets of post contrast images were acquired
in a craniocaudal direction after injection of the contrast med-
ium. The scanning delay was individualized for each patient by
using bolus-tracking software that measures the inﬂow of
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level examined and automatically triggers the start of the
examination when it registers a density of 100 HU. The ﬁrst
and second acquisitions were used for early and delayed hepa-
tic arterial phase imaging, the third acquisition for portal ve-
nous phase imaging, and the fourth acquisition to image the
hepatic venous phase.
Multiphasic CT scans were acquired, starting at the hepatic
dome and proceeding in a caudal direction to the lower margin
of the kidneys. Images were obtained during a single breath
hold. The following parameters were used: section collimation,
0.75 mm; section thickness, 1 mm; table feed, 12 mm per rota-
tion; rotation time, 0.5 s per rotation; 160 mAs; and 120 kVp.
Images were reconstructed at an interval of 0.7 mm. The ac-
quired data were transferred to a workstation equipped with
a dedicated 2D and 3D reconstruction softwares (Vitrea 2.2
and Syngo fast view) which allowed processing of multiplanar
reformatting (MPR), three-dimensional maximum intensity
projection (MIP), and volume rendering (VR) programs, to
generate multiplanar angiographic reconstructions.
2.2. Imaging evaluation and analysis
Imaging diagnosis of a shunt relied on direct detection of an
abnormal intrahepatic cystic or tubular structure that commu-
nicates two vessels. For further evaluation of a shunt the fol-
lowing parameters were analyzed by each modality; type
(determined from recognition of the identity of inﬂow and out-
ﬂow vessels), size (small, large or aneurismal), angioarchitec-
ture (simple or complex) and distribution (localized or
diffuse). The diameters of inﬂow and outﬂow vessels were also
assessed. Simple shunt has a single inﬂow vessel connected to a
single outﬂow vessel via a single communication. Complex
shunt consists of a network of inﬂow, outﬂow and communi-
cating vessels [7]. Any other associated intra or extrahepatic
ﬁndings were also assessed.
Furthermore, Doppler tracing was performed to assess the
inﬂow and outﬂow vessels both quantitatively (peak systolic
and diastolic ﬂow velocities and resistivity index in hepatic ar-
tery, mean ﬂow velocity in portal vein, diastolic peak ﬂow
velocity in hepatic vein) and qualitatively (ﬂow pattern and
ﬂow direction). Quantiﬁcation of blood ﬂow volume in the
shunt was measured by multiplying the lumen area by the
mean velocity. The shunt ratio was calculated by dividing
the total blood ﬂow volume in the shunt by that in the inﬂow
vessel [7,9,10].
Diagnosis and differentiation of various types of shunts on
CT relied on other additional indirect signs reﬂecting the blood
ﬂow alteration induced by the shunt. We focused on analyzing
the phase of contrast at which the inﬂow and outﬂow vessels
and their communicating shunt vessels were opaciﬁed and
whether there was any associated areas of transient hepatic
attenuation differences (THADs) reﬂecting underlying intra-
parenchymal perfusion disorders.
2.3. Strategy used for shunt management
In order to select appropriate management for patients diag-
nosed as having IHVSs, our team proposed a practical strategy
with therapeutic implication based on both imaging and clini-
cal ﬁndings and categorized patients into three groups as
follows:Group I included asymptomatic patients with small non
neoplastic shunts and with shunt ratio <30%. They were fol-
lowed up by duplex Doppler and clinical examination at 3–
6 months interval. If the shunt did not change or regressed
and no signs or symptoms developed, then conservative man-
agement was applied according to the type of shunt. If the
shunt increased in size or new shunts developed, shunt ratios
exceeded 30% or patients developed signs and symptoms,
then, interventional treatment was applied to prevent long
term development of complications or to improve the patients’
clinical condition.
Group II included patients with symptomatic shunts, pa-
tients with large or aneurismal shunts, patients with shunt ra-
tio >30% or patients with neoplastic shunts. They directly
underwent interventional management for their shunts alone
or as a bridge for surgery depending on the results of the inter-
ventional procedure applied.
Group III included patients with diffuse shunts or patients
with shunt ratio >60%. They were planned directly for
surgery.
2.4. Interventional procedures
All angiographic examinations were performed using digital
subtraction angiography unit (Inﬁnex, Toshiba Japan). Trans-
catheter embolization was performed for patients with arterio-
venous or portosystemic shunts via one of the following access
routes depending on the type of shunt:
 In patients with arteriovenous shunts a femoral artery
approach was adopted, using the Seldinger technique under
local anesthesia. Baseline digital subtraction angiography of
the celiac trunk and the superior mesenteric artery was per-
formed to visualize the liver vasculature and evaluate the
portal vein patency. The common hepatic artery, right
and left hepatic arteries were cannulated, and more superse-
lective cannulation of the feeders to the arteriovenous
shunts was performed, if indicated, with or without the
use of microcatheters (Terumo progreat 2.7 F, Terumo,
Japan). To avoid passage of the embolic agent into the sys-
temic circulation in patients with arterio-hepatic-venous
shunts we performed embolization after temporary balloon
occlusion of the hepatic vein through trans-jugular or trans-
femoral veins cannulation till the targeted hepatic vein and
balloon were delivered in the shunt vein and inﬂated for 10–
15 min during embolization time.
 In patients with portosystemic shunts a retrograde trans-
caval or transjugular obliteration of the shunt was per-
formed under local anesthesia by advancing two catheters
into the portal venous system. One catheter (Tracker 38,
BSJ, Tokyo, Japan) was used and advanced into the main
portal vein through the shunt to obtain a portogram and
measure portal venous pressure before and during emboli-
zation and the other catheter was used to place the embolic
material.
Different types of embolic agents were available and in-
cluded ﬁbered platinum coils, Gianturco steel coils, gel foam
particles, polyvinyl ethaline particles (PVA, Ivalon Contour
350-500 emboli; Boston Scientiﬁc, Mississauga, ON, Canada),
histoacryl (NBCA, N-butyl cyanoacrylate; B Braun, Melsun-
gen, Germany) mixed with lipiodol (Laboratoire Guerbet,
Table 1 Demographic and clinical characteristics of the
diagnosed IHVSs in 134 patients.
Characteristics Value data
Demographics
Age (years)
Mean (range) 46 (3–75)
Sex (number)
Males 82
Females 52
Clinical presentation No (%)
Portal Hypertension 7 (5%)
Hepatic Encephalopathy 7 (5%)
Heart Failure 1 (1%)
Extrahepatic HHT manifestations 8 (6%)
22 B.A.M. Dessouky et al.Roissy, France) at a ratio of 1:2. The choice of embolic agent
depended on the size and angioarchitecture of the shunt. In
large simple or aneurismal shunts we used coil embolization.
In complex shunts we used particle agents.
In patients with hepatic venovenous shunts due to underly-
ing Budd-Chiari syndrome we performed TIPS (transjugular
intrahepatic portosystemic shunt) using a non covered wall
stent (Boston Scientiﬁc, Mississuauga, USA) between the
IVC and intrahepatic portal vein main branches after balloon
dilatation of the track.
2.5. Assessment of embolization results
We reviewed our patients who underwent shunt embolization
and evaluated their radiological and clinical outcomes. The de-
gree of shunt occlusion based on the pre- and post-embolization
digital subtraction angiograms was evaluated and we divided it
into two categories: complete and partial occlusion. Complete
occlusion was deﬁned as absence of residual opaciﬁcation of
the shunt and the draining veins and was considered immediate
technical success. Partial occlusion was deﬁned as visible
evidence of a residual shunt and this was semi-quantitatively
divided into two subcategories: those with <80% reduction
and those withP80% reduction.
Patients with 80% or more reduction were arranged for re-
peated shunt embolization 6 months afterward using more
than one embolic material, if complete occlusion occured then
no more treatment was needed. If failed, then surgery would be
the next step. Patients with partial reduction of shunts <80%
underwent direct surgery. We set the criteria at 80% reduction
because the chance of sequential complete occlusion during
follow-up would be high as small shunts can spontaneously re-
solve with conservative treatment as was previously reported
[11].
3. Results
Among the 3143 patients included within the framework of
screening, a total of 134 (4.3%) patients were ﬁnally diagnosed
to have abnormal intrahepatic vascular shunts (IHVSs). They
were 82 males and 52 females. Their ages ranged from 3 to
75 years (mean, 46 years). At the time of entry into the study,
only 15 (11%) patients were presented with signs and symp-
toms speciﬁc for underlying shunts. The most common presen-
tation was portal hypertension in 7 (5%) patients with
arterioportal shunts. These patients had experienced various
manifestations including splenomegaly in 7 (5%) patients, asci-
tes in 6 (4.5%) patients, variceal hemorrhage in 6 (4.5%) pa-
tients and abdominal bruit in 2 (1.5%) patients (more than
one presentation could be present in the same patient). Hepatic
encephalopathy was manifested in 7 (5%) patients with porto-
systemic venous shunts in the form of disturbance of con-
sciousness, tremors, disorientation, and somnolence. The
most lethal presentation was high output heart failure in only
one (1%) patient who had combined (arterioportal and arte-
riohepatic) shunt characterized by shortness of breath, dysp-
nea on exertion and lower limb edema. Eight patients (6%)
with congenital arteriovenous shunts had associated extrahe-
patic manifestations of hereditary hemorrhagic telangiectasia
(HHT) in the form of epistaxis and mucocutaneous telangiec-
tases. Demographic and clinical characteristics are demon-
strated in Table 1.Two principle types of intrahepatic vascular shunts were ﬁ-
nally diagnosed. Type I were arteriovenous shunts in 96 (72%)
patients including isolated arterioportal shunts in 75 (56%) pa-
tients (Fig. 1), isolated arteriohepatic shunts in 20 (15%) pa-
tients (Fig. 2) and coexistence of both types of shunts in only
1 (1%) patient (ﬁg. 3). Type II were venovenous shunts in 38
(28%) patients, including portohepatic venous shunts in 17
(13%) patients (Fig. 4), portoportal shunts in 14 (10%)
patients (Fig. 5) and hepatic venovenous shunts in 7 (5%)
patients (ﬁg. 6).
The diagnosed intrahepatic vascular shunts (IHVSs) were
mostly acquired due to underlying HCC which represented
the most common etiology in 63 (47%) patients (Fig. 2). The
size of their maximal individual tumors ranged from 4 to
10 cm in all patients. Acquired non neoplastic causes were
determined in 63 (47%) patients including, transhepatic inter-
ventional procedures in 23 (17%) patients, liver cirrhosis in 14
(11%) patients (Fig. 4), traumatic liver injury in 11 (8%) pa-
tients, portal vein thrombosis in 10 (7%) patients (Fig. 6)
and Budd-Chiari syndrome in 5 (4%) patients (Fig. 6). Con-
genital etiology of the shunts was determined in 8 (6%) pa-
tients with hereditary hemorrhagic telangiectasis (HHT)
(Figs. 1 and 3). The different types of shunts and their associ-
ated etiologies are summarized in Table 2.
Imaging analysis of the size, angioarchitecture and distribu-
tion of shunts revealed that: 119 (89%) patients had small
shunts (mean diameter, 4.5 mm, range 3–6 mm), 43 of them
were simple and 76 were complex shunts [63 of them were asso-
ciated with HCC including 48 arterioportal and 15 arteriohe-
patic (Fig. 2)]. Eleven (8%) patients had large shunts (mean
diameter, 17 mm, range 15–23 mm) [10 were simple (ﬁg. 4)
and only one shunt was complex and diffusely distributed in
the liver (ﬁg. 3)] and 4 (3%) patients had aneurismal shunts
(mean diameter, 32 mm, range 28–45 mm) (Fig. 1, Table 3).
Ultrasonography and color Doppler ﬁndings evaluation re-
sults differed according to the type, size, angioarchitecture and
distribution of shunts. In small simple shunts (n= 43) there
were no detectable morphological changes of the inﬂow and
outﬂow vessels of the shunts and no alterations in their origi-
nal ﬂow velocity, pattern or direction as compared to the intra-
hepatic vessels of the same order.
 In small complex shunts (n= 76), the inﬂow and outﬂow
vessels and their vascular connections appear as small retic-
ular tortuous vascular network (Figs. 2A–C, 5A,B and
Table 3 Size and angioarchitecture of different types of IHVSs.
Type of shunts Size and angioarchitecture of shunts
Small (119, 89%) Large (11, 8%) Aneurismal (4, 3%)
Simple 43 (32%) Complex 76 (57%) Simple 10 (7%) Complex 1 (1%)
Arteriovenous (96, 72%)
Arterioportal (75, 56%) 20 48 5 – 2
Arteriohepatic (20, 15% 5 15 – – –
Combined (1, 1%) – – – 1a –
Venovenous (38, 28%)
Portohepatic (17, 13%) 10 – 5 – 2
Portoportal (14, 10%) 6 8 – – –
Hepatic venovenous (7, 5%) 2 5 – – –
a This shunt was diffusely distributed in the liver.
Table 2 Etiologies of the diagnosed IHVSs in 134 patients.
Etiologies of shunts Types of shunts
Arteriovenous (96, 72%) Venovenous (38, 28%)
Arterioportal
(75, 56%)
Arteriohepatic
(20, 15%)
Combined
(1, 1%)
Portohepatic
(17, 13%)
Portoportal
(14, 10%)
Venovenous
(7, 5%)
Acquired (126, 94%)
Neoplastic
HCC (63, 47%) 48 15 – – – –
Non neoplastic
Interventional procedures (23, 17%) 16 2 – 2 3 –
Cirrhosis (14, 11%) 1 – – 13 – –
Traumatic liver injury (11, 8%) 6 – – 2 1 2
Portal vein thrombosis (10, 7%) – – – 10 –
Budd Chiari syndrome (5, 4%) – – – – – 5
Congenital
HHT (8, 6%) 4 3 1 – – –
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velocities in arteriovenous shunts (n= 63) (mean systolic,
45; range 42–48 cm/s, and mean diastolic 18; range 17–
22 cm/s), pulsatile biphasic waveform pattern with pre-
served ﬂow direction in the draining portal and hepatic
venous branches (Fig. 2E). In venovenous shunts (n= 13)
the ﬂow velocities inside the inﬂow and outﬂow vessels were
decreased (mean, 10; range 9–15 cm/s, and mean, 22; range
20–26 cm/s in portoportal (Fig. 5C,D) and hepatic venove-
nous shunts (Fig. 6D,E), respectively), with continuous
monophasic ﬂow waveform patterns. The ﬂow directions
were reversed in the portal outﬂow vein (in portoportal
shunts) and hepatic inﬂow vein (in hepatic venovenous
shunts). The shunt ratios were <30% in all these patients
(mean, 20%; range 11–25%).
 In patients with large (n= 11) and aneurismal (n= 4)
shunts, blood was preferentially directed toward the shunt
in the inﬂow vessels and away from the shunt in the outﬂow
vessels in all the patients with consequent morphological
changes and alterations in the Doppler spectra that differed
according to the type of shunts as follows:
In patients with arteriovenous shunts (seven arterioportal
and one combined) the feeding hepatic arteries showedincreased diameters (mean, 66 mm, range 60–75 mm), tortuous
courses, increased ﬂow velocities (mean systolic, 100; range 80–
120 cm/s, and mean diastolic 45; range 40–56) and decreased
resistive indices (mean, 0.5, range, 0.45–0.6) associated with
intrahepatic arterial hypervascularization. The draining veins
showed increased diameters (mean, 13.5 mm, range 13.2–
16.5 mm), increased ﬂow velocities (mean 35 cm/s; range
27–60 cm/s) and arterialized biphasic waveform pattern. The
ﬂow inside the draining portal veins was reversed (Fig. 1B–F).
In patients with aneurismal portohepatic shunts (n= 7),
the portal branches leading to the shunts were dilated (mean
diameter, 15 mm,range 13–17 mm) with increased ﬂow veloci-
ties inside (mena, 56; range 50–68 cm/s) associated with reduc-
tion of portal perfusion of the hepatic parenchyma as assessed
by narrowing and slow ﬂow in the intrahepatic portal branches
not involved in the shunt. The draining hepatic veins showed
increased diameters (mean, 13.3 mm, range 13–15 mm) associ-
ated with alteration in its Doppler spectra in the form high
velocities (mean, 66; range 6–68 cm/s) and monophasic, con-
tinuous waveforms (Fig. 4B–F). Mean shunt ratio in all pa-
tients with large and aneurismal shunts was 55% (range 45–
78%) (Table 4).
Images obtained from multiphasic CT protocol and post-
processing techniques including MPR, MIP and VR allowed
Table 4 Ultrasonographic and color Doppler ﬁndings in the diagnosed 134 patients with IHVSs.
Ultrasonographic and color Doppler ﬁndings
Size and appearance
of shunts
Morphology of
inﬂow and outﬂow vessels
Hemodynamic parameters
Velocities in inﬂow and
outﬂow vessels
Waveform pattern in
the outﬂow vessel
Flow direction in
the outﬂow vein
Shunt ratio
(mean, range)
Small
Simple (n= 43) No changes No changes No changes No changes 20%; 11–25%
Complex (n= 76) Reticular network Mildly › in AV
ﬂ in VV shunts
Altered in AV and
VV shuntsa
Preserved in AP
Altered in VV shuntsb
Large (n= 11)
and
Aneurismal (n= 4)
Increased diameters
and tortuous courses
Arteriovenous shunts (n = 8) 55%; 45–78%
– › peak ﬂow velocities and
ﬂ RI in the hepatic arteries
– › mean ﬂow velocities in
the portal veins
Arterialized, biphasic Away from the shuntc
Portohepatic venous shunts (n = 7)
– › mean ﬂow velocities in
the portal veins
– › ﬂow velocities in the
draining hepatic veins
Continuous,
monophasic
No change
Abbreviations: AV = arteriovenous shunts, VV = venovenous shunts.
a Pulsatile biphasic in arteriovenous shunts and continuous monophasic in venovenous shunts.
b Reversed ﬂow was observed in the outﬂow vein in portoportal shunts and in the inﬂow vein in hepatic VV shunts.
c Inversion of ﬂow direction was observed in the draining portal veins.
24 B.A.M. Dessouky et al.us to directly visualize the communications between inﬂow and
outﬂow vessels in all projections. The type, size, angioarchitec-
ture and distribution of shunts as well as the identity, diameters
and courses of the inﬂow and outﬂow vessels were conﬁrmed by
CT. Other additional indirect CT signs allowed us to identify
and differentiate between various types of shunts. In all patients
with arteriovenous (arterioportal and arteriohepatic) shunts
(n= 96) we observed simultaneous opaciﬁcation of the hepatic
artery (inﬂow vessel) and the outﬂow venous branches (portal
vein in arterioportal shunts (Fig. 1G–M, hepatic veins in arte-
riohepatic shunts (Fig. 2F,G) or both veins in combined shunts
(Fig. 3E–G)) during the early arterial phase. This early venous
enhancement had approximately the same attenuation as that
of the hepatic arteries and persisted during the late arterial
and venous phases. In patients with portovenous shunts
(n= 38) the portal and hepatic veins did not opacify in the
arterial phase but both of them opaciﬁed simultaneously during
the porto-venous phase (Fig. 4G–L).Table 5 CT ﬁndings in the diagnosed 134 patients with IHVSs.
CT ﬁndings
Arteriovenous shunts (
I. Time of opaciﬁcation of shunt vessels
Early arterial phase –Simultaneous opaciﬁc
Late arterial phase –Persistent opaciﬁcatio
Portovenous phase –Persistent opaciﬁcatio
II. Parenchymal perfusion disorders (n = 16)
–Shape and distribution
–Time of opaciﬁcation
 Early arterial phase
 Late arterial phase
 Portovenous phase –Isodense to th
–Direction of the wedge of THAD Arteriovenous shunts (
Pointed toward the poIntraparenchymal perfusion disorders [transient hepatic
attenuation differences (THADs)] were another indirect signs
observed in a total of 16 (12%) of patients with IHVS; 10 pa-
tients had arterioportal shunts, 1 patient had combined arterio-
portal and arteriohepatic shunts associated with HHT
(parenchymal hepatic telangiectasis) (Fig. 3 E–G) and the
remaining 5 patients had obstructed hepatic veins due to
Budd-Chiari syndrome (Fig. 6 F,G). These perfusion disorders
appeared as peripheral wedge or globular shaped areas with
regular contours characterized by early enhancement that
persisted during both arterial phases and either returned to
normal attenuation on portal-venous phase images in arterio-
venous (AV) shunts or persisted in the venous phase in venove-
nous (VV) shunts due to venous occlusion. The edge of the
wedge shaped areas of THADs, pointed toward the portal hilus
in arterioportal shunts and toward the vena cava in hepatic vein
occlusions. The intrahepatic CT ﬁndings of shunts are summa-
rized in Table 5.n= 96) Venovenous shunts (n= 38)
ation –No opaciﬁcation
n –No opaciﬁcation
n –Simultaneous opaciﬁcation
–Peripheral wedge shaped or globular areas
–Early enhancement
–Persistent enhancement
e liver in AV shunts or persisted enhancement in VV shunts
n= 11) Venovenous shunts (n= 5)
rtal hilus Pointed toward the vena cava
Figure 1 A 5-year-old child with congenital aneurismal arterioportal shunt, manifested by portal hypertension. (A) Gray-scale
sonogram shows a cystic structure (long arrow) adjacent to the hepatic vessels which are dilated and tortuous (short arrows). (B) Color
Doppler ultrasound clearly identiﬁes direct connection of the hepatic artery to the portal vein via a vascular aneurysm (long arrow) with
reversal of ﬂow in the portal vein (short arrow). (C) Power Doppler sonogram shows adequate morphological evaluation of the aneurismal
shunt (long arrow), feeding and draining vessels (short arrows) and associated hypervascularity of the surrounding liver parenchyma
(thick arrow). (D–F) Spectral Doppler tracing of the hepatic artery shows high systolic and diastolic ﬂow velocities (D), bidirectional ﬂow
throughout the aneurismal shunt (E) and arterialized reversed ﬂow in the draining portal vein (F) consistent with arterioportal shunting.
(G–I) Early arterial phase axial CT scans at different levels show early opaciﬁcation of the portal vein (thick arrow) adjacent to the hepatic
artery (thin arrows) (G), conﬁrming arterioportal shunt. The aneurismal site of communication is seen on cranial CT scans (H and I)
(arrows). Three dimensional MIP (J) and VR angiographic reconstructions (K–M) allow better angiographic details of the aneurismal
shunt (long arrows), inﬂow and outﬂow vessels (short arrows) in axial anterior (K), posterior (L) and anterior coronal (M) orientations.
(N) Pre-embolization selective DSA of the main hepatic artery conﬁrms the aneurismal arterioportal shunt (long arrow) with retrograde
ﬁlling of the main portal vein (short arrow). (O) Postembolization assessment revealed complete occlusion of the shunt by coils.
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Figure 2 A 55-year-old woman with hepatocellular carcinoma and arteriohepatic venous shunt. (A) Gray-scale sonogram shows an
isoechoic mass in the left lobe of the liver surrounded by anechoic tortuous and tubular structures (arrow). (B) Color ﬂow mapping, and
(C) power Doppler images show a complex shunt (thick arrows) communicating intra- (black arrows) and perilesional (white arrows)
vessels. (D and E) Spectral Doppler tracing reveals mild increased systolic and diastolic velocities in the intralesional arterial vascularity
(D) with pulsatile biphasic ﬂow in the adjacent hepatic vein (E) consistent with arteriohepatic venous shunting. (F and G) Contrast-
enhanced axial CT images in the early arterial phase at two levels show simultaneous ﬁlling of contrast of the aorta and hepatic arteries
(long arrows) and hepatic veins and IVC (short arrows) representing arteriosystemic venous shunting due to a heterogeneously enhanced
mass (thick arrows) that shows early venous drainage with complete washout of its contrast in the venous phase image (thick arrow) (H)
consistent with HCC. (I) Three dimensional oblique coronal VR angiographic reconstruction image allows good morphological and
angiographic details. (J) Pre-embolization selective DSA of the main hepatic artery conﬁrms the presence of neoplastic arteriosystemic
shunt with retrograde ﬁlling of the draining hepatic veins adjacent to the mass (black arrows). (K) Postembolization assessment revealed
<80% reduction of the shunt and the patient underwent surgery.
26 B.A.M. Dessouky et al.Following the protocol of management proposed by our
team we found that: 56 (42%) asymptomatic patients had
small non neoplastic shunts and their shunt ratios were
<30% (group I). These patients were subjected to close mon-
itoring by duplex Doppler and clinical follow-up. After
3 months regression of the shunts was observed in 33 patients
(20 had arterioportal and 5 had arteriohepatic venous shunts
and 8 portoportal shunts), while in 18 patients (10 had porto-
hepatic 6 had portoportal and 2 had hepatic venovenous
shunts) the shunt sizes remained constant, and all thesepatients did not develop any signs or symptoms and their
shunt ratios were <30%. In the remaining 5 patients with he-
patic venovenous shunts, new shunts developed, shunt ratios
exceeded 30%, with marked attenuation of the hepatic veins
after 6–12 months and the patients developed manifestations
of complications (ascites and varices). These patients under-
went TIPS.
Seventy-seven (57%) patients were categorized under group
II. This group included 14 symptomatic patients with shunt ra-
tios exceeded 40%; 10 patients had large simple shunts and 4 pa-
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small complex shunts associated with HCC were also catego-
rized under this group. Interventional treatment was immedi-
ately applied for these patients including coil embolisation in
patients with large or aneurismal shunts and chemoemboliza-
tion using histoacryl or gel foam with simultaneous injection
of chemotherapeutic agent (TACE) in patients with HCC.
Postembolization assessment revealed complete occlusion in aFigure 3 A 6-year-old child with HHT, combined arterioportal an
manifested by heart failure. (A) Color ﬂow mapping shows dilated to
associated with a vascular network inside the left liver lobe (thick arrow
portal vein and hepatic vein branches in this network with high sys
arterialized ﬂow in the portal (C) and hepatic (D) veins with reversed ﬂ
arteriosystemic shunt. (E and F) Axial CT images at two different leve
phase show simultaneous opaciﬁcation of the hepatic veins and IVC (
arrow), better evident in the coronal image (G) due to underlying com
(between arrows). The liver parenchyma is heterogeneous because o
triangular and globular enhancing areas (THADs) (arrowheads) due ttotal of 12 (8%) patients (10 had large simple shunts and 2
had aneurismal shunts), >80% reduction in a total of 56
(42%) patients (2 had aneurismal shunts and in 54 had neoplas-
tic shunts) and <80% reduction in the remaining 9 (7%) neo-
plastic shunts. Subsequent embolization was arranged
6 months afterward for the 56 patients with >80% reduction
and we could no longer monitor any shunts in postembolization
angiograms. Patients with <80% reduction of their neoplasticd arteriosystemic venous shunts and hepatic perfusion disorders
rtuous portal vein (long arrow), and hepatic artery (short arrow)
). (B–D) Spectral tracing reveals involvement of the hepatic artery,
tolic and diastolic ﬂow velocities in the hepatic artery (B), and
ow in the portal vein consistent with a combined arterioportal and
ls and (G) coronal oblique 3D MIP image during the early arterial
thick arrows), portal vein (long arrows), and hepatic artery (black
bined arteriosystemic and arterioportal intraparenchymal shunts
f the presence of several telangiectases with multiple peripheral
o underlying parenchymal perfusion disorders.
Figure 4 A 60-year-old male patient with aneurismal portohepatic venous shunt, undergoing evaluation for cirrhosis and presented by
hepatic encephalopathy. (A) Gray scale sonogram shows a cystic appearing lesion adjacent to the hepatic vessels (arrow). Color ﬂow (B)
and power Doppler (C) sonograms show direct connection of the right portal vein branch (short arrows) with the right hepatic vein (thick
arrows) through an aneurysm (long arrows). (D–F) Doppler spectral tracing shows a high ﬂow velocity with cardiac modulation of the
spectrum within the portal vein due to the transmission through the shunt of the cardiac related ﬂow oscillations of the efferent hepatic
vein (D), helicoidal bi-directional wave within the aneurismal portovenous shunt (E), and a ﬂattened, turbulent, high velocity waveform
within the draining hepatic vein (F). Axial (G–I) and coronal (J–L) reformatted contrast-enhanced portal venous phase and angiographic
MIP CT images show an aneurismal shunt communication (long arrows) between the right portal vein (short arrows) and the right hepatic
vein (thick arrows). (M) Pre-embolozation hepatic venogram shows intrahepatic portosystemic venous shunt (long arrow) between the
right portal vein (short arrow) and the right hepatic vein (thick arrow). (N) Postembolization assessment shows complete obliteration of
the shunt by coils.
28 B.A.M. Dessouky et al.shunts proceeded to surgical reconstruction of shunts and hep-
atectomy after satisfactory shunt and tumor control by
chemoembolization.Group III included only one (1%) patient with combined
(arterioportal and arteriohepatic) complex shunt diffusely dis-
tributed in the liver. This patient had shunt ratio >60% and
Figure 5 A 45-year-old male patient with portoportal shunts due to underlying main portal vein thrombosis. (A and B) Color and power
Doppler sonograms show cavernous transformation of the thrombosed main portal vein (long arrows) with a reticular network of small
portal vessels at and close to the liver hilum connecting the left portal branches with the right portal branches (short arrows). (C and D)
Spectral tracing shows slow ﬂow velocities with continuous monophasic ﬂow pattern in the inﬂow and outﬂow vessels and reversed ﬂow in
the outﬂow vessels. Portovenous phase axial (E and F) and coronal MIP (G and H) images conﬁrm the ultrasonographic ﬁnding of
cavernous transformation of the thrombosed main portal vein (long arrows) with direct portoportal connections (short arrows). (J)
Follow-up color ﬂow mapping shows partial recanalization of the main portal vein (long arrow) with regression of the size and number of
the shunt vessels (short arrow).
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transplantation.
Close clinical and ultrasonographic follow-up was applied
and advised at 6–12 months intervals for all the patients andprophylactic medical therapy which consists of a protein-free
diet and oral administration of lactulose, branched-chain ami-
no acids and non absorbable antibiotics was administered for
patients with portovenous shunts and anticoagulant therapy
Figure 6 A 21-year-old female patient with hepatic venovenous shunts due to underlying Budd-Chiari syndrome. (A) Gray scale US
demonstrates an echogenic web constricting the IVC (long arrow). (B and C) Color and power Doppler sonograms show focal color
aliasing in the IVC (long arrow) indicating a stenosis at that level and a network of ﬁne venovenous collateral vessels (short arrows). (D
and E) Doppler tracing of the IVC (D) and collateral vessels (E) show weak monophasic continuous ﬂow with loss of the normal triphasic
appearance. Note and a thrombus narrows hepatic vein conﬂuence (short arrow). (F and G) Coronal portovenous phase images show
inhomogeneous enhancement of the liver, enlarged caudate lobe (long arrow) with wedge shaped and globular areas of hepatic attenuation
differences (thick arrows) persisted during the portovenous phase with partial obstruction of the IVC by a thrombus (short arrow). Axial
MIP (H) image obtained from portovenous phase conﬁrm the presence of spider web network of venovenous collaterals (arrows). (I–M)
Color and power Doppler follow up after 6 months shows development of new collaterals (short arrows) that follow the same track of the
stenosed right hepatic vein and connecting it to neighboring middle hepatic vein results in presence of ‘‘bicolored’’ hepatic veins (long
arrows). A large caudate lobe vein (K) (long arrow) and a large tortuous subcapsular vein (L) (thick arrow) that drain directly into the
IVC were developed and reversed ﬂow was observed in the main and branches of the right portal vein creating new intrahepatic and
extrahepatic shunts (M) (arrowhead). Note the presence of ascites (short arrow). The patients presented by manifestations of portal
hypertension. TIPS was performed with balloon dilatation of the track through a transjugular approach (N) (long arrow) then a stent was
placed to connect the IVC with the portal vein (O) (short arrow).
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Figure 7 Chart illustrates application of the proposed strategy for managing the diagnosed 134 patients with IHVSs.
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to prevent further development of complications. The algo-
rithm used for management is illustrated in Fig. 7.
4. Discussion
Diagnosis of intrahepatic vascular shunts (IHVSs) has been
long considered challenging and many times it is made inciden-
tally [1,10,12]. Early diagnosis and proper management of
intrahepatic vascular shunts is very important in both symp-
tomatic and asymptomatic patients [12]. Our study ﬁndings
conﬁrmed what was previously reported by many investigators
(12-17) as we found that liver involvement by intrahepatic vas-
cular shunts was asymptomatic in the majority 89% of our pa-
tients, and when symptomatic (in 11%) they were presented by
severe complications including portal hypertension (in 5%),
portosystemic encephalopathy (in 5%), and congestive cardiac
failure (in 1%). Moreover, recent publications [13–15] reported
that the interval between the formation of the ﬁstula and its
recognition can range from hours to years. That is why we
screened a large group of patients who were liable to develop
intrahepatic vascular shunts aiming to reduce the risk of dete-
rioration of serious complications, or to prevent their develop-
ment. Due to its ease of use, non-invasiveness and availability,
we proposed ultrasonography and color Doppler imaging as
the initial screening test. We complemented our imaging eval-
uation of the detected IHVSs by a more accurate imaging
method using multidetector CT protocols as detection of these
malformations should always prompt careful evaluation in an
attempt to identify other diagnostic criteria and conﬁrm ultr-
asonographic ﬁndings. Angiography is an invasive and expen-
sive procedure that previously was the most useful imaging
method for the assessment of vascular abnormalities
[12,16,17], but in our study, considering the fact that liver
involvement is asymptomatic in most cases, it was indicated
only in selected cases for interventional management
(Figs. 1,2,4,6).Previous publications [1,2,4,5,8,11] had reported that three
types of intrahepatic shunts between the major vessels of the
liver were possible including: arterioportal shunts (hepatic ar-
tery to portal vein), arteriosystemic shunts (hepatic artery to
hepatic vein), and portosystemic venous shunts (portal vein
to hepatic vein or vena cava). Bodner et al. [6] added another
two types to their classiﬁcation including portoportal shunts
(between portal veins) and hepatic venovenous shunts (be-
tween hepatic veins). In order to simplify their description
we classiﬁed the diagnosed IHVSs in 134 patients into two ma-
jor types; arteriovenous shunts in 72% and venovenous shunts
in 28% of our patients. We found that arterioportal shunts,
were the most common type identiﬁed in 57% of our patients.
They were presented as isolated arterioportal shunts in 56% of
patients and coexisted with arteriohepatic shunts in only 1% of
our patients. Portohepatic shunts were identiﬁed in 13%, por-
toportal shunts in 10% and hepatic venovenous shunts in 5%
of our patients.
Our study results have proved that intrahepatic vascular
shunts were more frequent than was previously reported by
other authors [18–33]. Intrahepatic vascular shunts were iden-
tiﬁed in 4.3% of the screened 3143 patients. This is likely as we
relied mainly on imaging ﬁndings for diagnosis as compared
with others [26,28,31] who depended on clinical ﬁndings alone
and also due to the higher general sensitivity of the imaging
methods we used in detecting hepatic alterations. This is also
attributed to the prevalence of intrahepatic vascular shunt par-
ticularly arterioportal and arteriosytemic shunts in patients
with HCC (47%) and in patients who underwent percutaneous
transhepatic procedures (17%) and moreover, due to the high
incidence of portosystemic shunts in patients with cirrhosis
(11%). These patients constituted a large group of patients
who were routinely managed in our departments. Researchers
show that the prevalence of arterioportal shunting in HCC is
as high as 63% of patients [1,12,13,17]. Other articles stated
that arteriosystemic shunts are typically associated with benign
and malignant liver neoplasms. This was explained by the fact
32 B.A.M. Dessouky et al.that the hepatic artery supplies HCC almost exclusively and
the tendency for these neoplasms to grow in the portal or he-
patic veins causes the venules to act as efferent vessels for the
tumor [1,6,7]. A previous article had reported that incidence of
intrahepatic shunts has increased in the last years because of
the greater use of transhepatic interventional procedures [1].
In our study the prevalence of portosystemic shunts in patients
with liver cirrhosis, portoportal shunts in patients with portal
vein thrombosis and hepatic venovenous shunts in patients
with Budd-Chiari syndrome were nearly the same as the prev-
alences previously reported by many investigators [6,32,34,35].
We found that congenital etiology due to underlying heredi-
tary hemorrhagic telangiectasis was determined in 6% of our
diagnosed shunts and were mainly associated with arteriove-
nous shunts.
Diagnostic imaging has a fundamental role in the identiﬁca-
tion of hepatic vascular alterations. Apart from diagnosis and
differentiation of various types of shunts it is crucial to evalu-
ate the shunt comprehensively in order to select appropriate
management speciﬁc for each patient [12,17]. Color Doppler
ultrasonography (CDUS) has proved useful in the detection
of various intrahepatic vascular ﬁstulas and has the additional
advantage over other imaging modalities that it enables ﬂow
direction, ﬂow velocity, and type of blood ﬂow (i.e., arterial,
portal, or hepatic venous) to be determined noninvasively
[2,3,6,9,10]. These facts had made color Doppler ultrasonogra-
phy very beneﬁcial for imaging evaluation of IHVSs in our
study as it provided us with baseline qualitative and quantita-
tive morphological and hemodynamic road maps of the liver
vasculature that helped us for selection of the appropriate
management and follow up purposes. Recent publications con-
cluded that it obviates the need for angiography as it is also
able to measure shunt ratios and may be potentially useful in
follow up and helping choose the appropriate therapeutic op-
tion of IHVS [2,3,10], although the main limitation is low sen-
sitivity and spatial resolution in the detection of small
arteriovenous shunts [2,3]. In our study we did not meet this
limitation as we did not rely for diagnosis of small shunts
(89%) on direct visualization of the shunt only but we also
we routinely use spectral analysis of shunt vessels for all the
patients and conﬁrm our evaluation by multiphasic CT. In
addition, ultrasonography combined with color Doppler al-
lowed us to diagnose all the patients with large and aneurismal
shunts (11%) easily and conﬁrmed the previously reported
sonographic criteria for liver involvement by shunts which in-
cluded dilatation and increased ﬂow velocity of the involved
vessels associated with inversion and arterialization of the
draining portal ﬂow in arterioportal shunts and disruption of
the normal triphasic pattern of the draining hepatic vein in
arteriohepatic shunts [2–6]. The diagnosis of intraparenchymal
portosystemic ﬁstulas is based on direct visualization of a di-
lated portal vein communicating directly with a hepatic vein
[21,25,26]. The high accuracy of these criteria for detecting
intrahepatic shunts has led some authors to consider CDUS
sufﬁcient for diagnosis in asymptomatic subjects, with more
invasive tests, such as CT, MRI or DSA being reserved for
symptomatic subjects [36–38].
The introduction of multidetector row CT (MDCT) devices
which allow for a dynamic multiphase study has facilitated
detection of IHVS. The examination protocol consisting of
early and delayed arterial phases and a portovenous phase
and signiﬁcant ﬁndings for identifying and differentiating thevarious types of shunts have been standardized [1,39–41].
Using multidetector row CT scanners in our study, enabled
us to perform a complete multiphasic study of the hepatic vas-
cular system and a good quality multiplanar reformatting
(MPR) and angiographic (maximum intensity projection,
MIP; and volume rendering, VR) reconstructions, thus offers
a more accurate and global visualization of these shunts. In
addition we relied on other indirect ﬁndings based on the time
of opaciﬁcation of the affected vascular branches during mul-
tiphasic study as well as the underlying parenchymal perfusion
changes that could not only diagnose the presence of shunt but
also specify the type of shunt and the vessels involved. Intrahe-
patic perfusion disorders, in the form of transient hepatic
parenchymal enhancement were observed in 16 of our patients
and were particularly associated with arterioportal shunts in
10 patients. These enhancement disorders were also observed
in I patient with combined arterioportal and arteriohepatic
shunts and in 5 patients with Budd-Chiari syndrome. They
were presented typically as was previously described [37,39]
as wedge-shaped or globular areas of enhancement during
the arterial phase, which become isoattenuating in the portal
venous phase in arteriovenous shunts but persisted in patients
with hepatic vein obstruction.
The optimal therapy for IHVS remains controversial.
Deﬁnitive therapy aimed at obliteration of the shunt and res-
toration of normal hemodynamics of the liver vasculature
[12,42]. Herein, we proposed a practical strategy based on
our experience and review of the literature that categorized pa-
tients into three groups according to the line of management
that was considered suitable according to the clinical and
imaging ﬁndings of each group. The speciﬁc way of manage-
ment we selected depended on whether the patient was symp-
tomatic or not, and also on the size of the shunt, shunt ratio
and whether it was associated with HCC. Previous publica-
tions had reported that large intrahepatic shunts are more of-
ten associated with clinical manifestations of shunt
complications than small shunts, as the higher degree of shunt-
ing due to larger shunts were responsible for early clinical man-
ifestations. When the shunt ratio is less than 30% symptoms
associated with IHVS may not develop throughout the life
time of the individual. When the shunt ratio exceeds 30%, clin-
ical manifestations may develop at any time. When the shunt
ratio exceeds 60% even without manifestations the risk of
complications is increased this is an indication for immediate
intervention [2,4,9,12].
Emergency intervention was not required in 56 (42%) of our
patients categorized under group I. These patients had small
non neoplastic shunts and their shunt ratios were <30% and
consequently the patients were asymptomatic and there was en-
ough time to follow-up their shunts and re-evaluated them,
both clinically and by duplex Doppler examination. As esti-
mated in previous articles [12,17,34] small shunts thrombosed
and closed spontaneously in most patients. In our study, the
shunts regressed in 33 patients, while remained unchanged in
18 patients after 3 months by follow-up duplex Doppler exam-
inations. However, in the remaining 5 patients who had Budd-
Chiari syndrome and hepatic venovenous collaterals new
shunts developed and the patients had manifestations of com-
plications and underwent TIPS. Embolization was clearly indi-
cated in a total of 77 (57%) patients constituting group II to
avoid more deterioration in 14 symptomatic patients with large
and aneurismal with shunt ratio exceeding 40% or to improve
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complex shunts. Our concept was to treat the shunt and HCC
at the same setting. Transcatheter embolization now affords a
relatively safe, inexpensive and practical method for treatment
of IHVS [25,32,43–45]. Compared with surgery, it carries the
advantage of reduced morbidity, repeated access availability
and reduced costs. Shorter hospital stay and decreased pain
are speciﬁc advantages [1,43,44]. Different embolic agents were
reported to achieve shunt embolisation with different degrees of
occlusion [12,19,25,32,43–45].
The reason for choosing particular embolic agents is seldom
mentioned [7]. In the current study, our choice of embolic
agents was based on good understanding of the underlying
mechanism of the shunts and their angioarchitecture. We pre-
ferred to use coils in 14 patients with large simple and aneur-
ismal shunts than gel foam particles, because the latter could
have been passed through the ﬁstula and ended up in the
splanchnic circulation. Embolization alone using coils
achieved complete occlusion of the shunts with subsequent dis-
appearance of symptoms in 12 patients, and >80% reduction
of shunts with improvement of the patients’ clinical condition
in another 56 patients (2 had aneurismal and 54 had neoplastic
shunts). This could be due to the use of relatively small coils in
the 2 patients with aneurismal shunts or the complex nature of
neoplastic shunts. Repeated embolization was successfully per-
formed for them 6 months later using larger coils in aneurismal
shunts and histoacryl combined with gel foam in neoplastic
shunts. We yet achieved <80% reduction of shunts in 9 pa-
tients with HCCs but at least the chemoembolization proce-
dures downgraded the HCCs and improved the prognosis for
these patients. These patients needed further surgery as the
next step and surgical approaches included vascular repair of
the shunt and partial hepatectomy.
Liver transplantation was the only suitable approach se-
lected for one of our patients who had congenital coexistence
of arterioportal and arteriosystemic shunts. The shunt was dif-
fusely distributed in the liver and we expected great difﬁculty
to be managed by embolization particularly with the very
bad clinical manifestation of the patient. To date, no cases
of congenital shunts closed spontaneously have been reported.
In such cases with advanced symptoms, the therapeutic role of
hepatic arterial embolization has been proposed [28,30] but is
controversial because of its unpredictable results and associa-
tion with a high risk of fatal hepatic necrosis; thus, liver trans-
plantation remains the only therapeutic possibility [4,5,12].
5. Conclusion
Routine follow-up of patients who were liable to develop intra-
hepatic vascular shunts using color duplex Doppler ultraso-
nography complemented by multiphasic multidetector CT
protocols and familiarity of the imaging characteristics of var-
ious types of shunts allowed early and accurate diagnosis and
comprehensive evaluation of intrahepatic vascular shunts. This
was important to prevent development of serious complica-
tions or more deterioration of the affected patients. This was
achieved by early selection of the appropriate line of manage-
ment suitable for each patient. Based on combined imaging
and clinical ﬁndings, our management strategy allowed uni-
form and practical therapeutic recommendations and yielded
satisfactory results and good prognosis for all patients.References
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